Axcelis Technologies, Inc. (NASDAQ:ACLS – Free Report) – Research analysts at William Blair decreased their Q1 2025 earnings per share estimates for Axcelis Technologies in a research report issued on Wednesday, November 13th. William Blair analyst J. Dorsheimer now anticipates that the semiconductor company will earn $1.06 per share for the quarter, down from their prior estimate of $1.41. The consensus estimate for Axcelis Technologies’ current full-year earnings is $5.86 per share. William Blair also issued estimates for Axcelis Technologies’ Q2 2025 earnings at $1.15 EPS, Q3 2025 earnings at $1.40 EPS, Q4 2025 earnings at $1.57 EPS and FY2025 earnings at $5.19 EPS.
A number of other equities analysts also recently commented on the company. Needham & Company LLC reissued a “hold” rating on shares of Axcelis Technologies in a research report on Friday, November 8th. Benchmark cut shares of Axcelis Technologies from a “buy” rating to a “hold” rating in a report on Friday, November 8th. Finally, B. Riley dropped their price objective on shares of Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research report on Friday, August 2nd. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $167.33.
Axcelis Technologies Trading Down 1.5 %
ACLS opened at $72.14 on Monday. The company has a debt-to-equity ratio of 0.04, a current ratio of 4.45 and a quick ratio of 3.29. The stock has a market capitalization of $2.34 billion, a price-to-earnings ratio of 10.83, a PEG ratio of 2.28 and a beta of 1.60. The business has a fifty day moving average price of $94.75 and a 200 day moving average price of $112.56. Axcelis Technologies has a 12 month low of $71.64 and a 12 month high of $158.61.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. lifted its position in Axcelis Technologies by 6.5% in the first quarter. Vanguard Group Inc. now owns 4,304,516 shares of the semiconductor company’s stock valued at $480,040,000 after acquiring an additional 263,604 shares during the last quarter. State Street Corp lifted its holdings in shares of Axcelis Technologies by 1.5% in the 3rd quarter. State Street Corp now owns 1,233,282 shares of the semiconductor company’s stock valued at $129,310,000 after purchasing an additional 18,101 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Axcelis Technologies by 3.3% in the 3rd quarter. Geode Capital Management LLC now owns 874,516 shares of the semiconductor company’s stock valued at $91,708,000 after purchasing an additional 28,141 shares during the period. Reinhart Partners LLC. grew its stake in Axcelis Technologies by 64.1% during the 3rd quarter. Reinhart Partners LLC. now owns 687,608 shares of the semiconductor company’s stock worth $72,096,000 after buying an additional 268,560 shares during the last quarter. Finally, BNP PARIBAS ASSET MANAGEMENT Holding S.A. increased its position in Axcelis Technologies by 12.1% during the third quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 510,894 shares of the semiconductor company’s stock worth $53,568,000 after buying an additional 55,048 shares during the period. 89.98% of the stock is owned by hedge funds and other institutional investors.
About Axcelis Technologies
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.
Further Reading
- Five stocks we like better than Axcelis Technologies
- How to Buy Cheap Stocks Step by Step
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- What is a Dividend King?
- Applied Materials Market Capitulates: Now is the Time to Buy
- Top Biotech Stocks: Exploring Innovation Opportunities
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.